Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Dec 9;8(12):e022136.
doi: 10.1136/bmjopen-2018-022136.

Individual cognitive stimulation therapy for people with intellectual disability and dementia: protocol of a feasibility randomised controlled trial

Affiliations
Randomized Controlled Trial

Individual cognitive stimulation therapy for people with intellectual disability and dementia: protocol of a feasibility randomised controlled trial

Afia Ali et al. BMJ Open. .

Abstract

Introduction: Cognitive stimulation therapy (CST) is a psychosocial intervention for dementia. Group CST is effective in reducing cognitive decline and improving quality of life in patients with dementia. There is some evidence that individual CST (iCST) may be beneficial in reducing cognitive decline. People with intellectual disability (ID) have an increased risk of dementia. However, there are no published studies of CST in people with ID and dementia. This protocol describes the feasibility and acceptability of a randomised controlled trial of iCST delivered by carers to people with ID and dementia, compared with treatment as usual (TAU). The results of this study will inform the design of a future definitive randomised controlled trial.

Methods and analysis: The iCST intervention has been adapted for this trial. Forty dyads (individuals with ID and their carer) will be randomised to either iCST or TAU. The manualised intervention comprises 40 iCST sessions delivered by a carer for 30 min, twice a week, over 20 weeks. The primary outcome will be process measures assessing the feasibility and acceptability of the intervention and trial procedures. The secondary outcome will be changes in the scores of outcome measures (cognition, functional ability and quality of life in individuals with ID, and caregiver burden, competence in managing dementia, and anxiety and depression in carers). Data will be collected at baseline, 11 weeks and at 21 weeks. A process evaluation will examine adherence to iCST and will include qualitative interviews with participants to identify aspects of the intervention that were or were not successful.

Ethics and dissemination: The study has received ethical approval. The results of the study will be presented at conferences and submitted to a peer reviewed journal.

Trial registration number: ISRCTN18312288; Pre-results.

Keywords: cognition; cognitive stimulation therapy; dementia; funtioning; intellectual disability.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Trial flow chart illustrating the flow of participants through the study from referral through to analysis of data. The number of participants who are referred and are eligible will be recorded as will the number of people who are eligible and agree to be randomised. Reasons for participant withdrawal/dropout will be recorded. iCST, individual cognitive stimulation therapy; TAU, treatment as usual.

Similar articles

Cited by

References

    1. Strydom A, Chan T, King M, et al. . Incidence of dementia in older adults with intellectual disabilities. Res Dev Disabil 2013;34:1881–5. 10.1016/j.ridd.2013.02.021 - DOI - PubMed
    1. McCarron M, McCallion P, Reilly E, et al. . A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome. J Intellect Disabil Res 2017;61:843–52. 10.1111/jir.12390 - DOI - PubMed
    1. Englund A, Jonsson B, Zander CS, et al. . Changes in mortality and causes of death in the Swedish Down syndrome population. Am J Med Genet A 2013;161A:642–9. 10.1002/ajmg.a.35706 - DOI - PubMed
    1. Bahar-Fuchs A, Clare L, Woods B. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia. Cochrane Database Syst Rev 2013;5:CD003260. - PMC - PubMed
    1. Clare L, Linden DE, Woods RT, et al. . Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: a single-blind randomized controlled trial of clinical efficacy. Am J Geriatr Psychiatry 2010;18:928–39. 10.1097/JGP.0b013e3181d5792a - DOI - PubMed

Publication types

Associated data